MONTHYEARML18030A7722018-01-26026 January 2018
Framatome, Inc., Submittal of Revision to a Response to Request for Information Regarding Areva Inc. Topical Report ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation
Project stage: Request
ML18058B9602018-03-22022 March 2018
Transmittal of Draft Safety Evaluation for Topical Report ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation.
Project stage: Draft Approval
ML18116A4692018-04-23023 April 2018
Response to Request for Comment on Draft Safety Evaluation for Framatome Inc. Topical Report ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation
Project stage: Request
ML18149A5902018-05-25025 May 2018
Resolution of Comments on Draft Safety Evaluation for Topical Report ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation (Non-Proprietary Version)
Project stage: Draft Approval
ML18120A3542018-05-25025 May 2018
Final Safety Evaluation for Framatome Inc. Topical Report ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation
Project stage: Request
ML18149A5672018-05-25025 May 2018
Final Safety Evaluation for ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation (Non-Proprietary Version)
Project stage: Approval
ML18120A3572018-05-25025 May 2018
Transmittal of Final Safety Evaluation for Topical Report ANP-10335P, Revision 0, Ace/Atrium 11 Critical Power Correlation.
Project stage: Approval
ML18179A1272018-07-17017 July 2018
Request for Withholding Information from Public Disclosure in April 23, 2018, Response for Comment on Draft Safety Evaluation for ANP-10335P, Revision 0
Project stage: Draft Approval
ML18170A0032018-07-17017 July 2018
Proprietary Determination Letter for Topical Report ANP-10335 Request for Additional Information Responses
Project stage: RAI
ML18234A1002018-09-13013 September 2018
Verification of Approval Version of Framatome Inc., Topical Report ANP-10335P-A, Revision 0, Ace/Atrium 11 Critical Power Correlation
Project stage: Other
2018-04-23
[Table View] |